More bad news for those that have disease with no treatment
April 26, 2016 at 15:33 PM EDT
FDA panel voted not to give Sarepta’s Duchenne muscular dystrophy drug a recommendation.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.